home / stock / kblmw / kblmw quote
Last: | $0.172 |
---|---|
Change Percent: | -3.37% |
Open: | $0.178 |
Close: | $0.172 |
High: | $0.1858 |
Low: | $0.1701 |
Volume: | 82,489 |
Last Trade Date Time: | 11/06/2020 04:56:23 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.172 | $0.178 | $0.172 | $0.1858 | $0.1701 | 82,489 | 11-06-2020 |
$0.178 | $0.18 | $0.178 | $0.2 | $0.1701 | 136,553 | 11-05-2020 |
$0.18 | $0.17 | $0.18 | $0.18 | $0.17 | 120,922 | 11-04-2020 |
$0.18 | $0.2 | $0.18 | $0.2 | $0.1612 | 155,336 | 11-03-2020 |
$0.2049 | $0.2049 | $0.2049 | $0.2049 | $0.1801 | 179,685 | 11-02-2020 |
$0.1985 | $0.1991 | $0.1985 | $0.208 | $0.1985 | 22,250 | 10-30-2020 |
$0.208 | $0.203899 | $0.208 | $0.2185 | $0.1985 | 48,180 | 10-29-2020 |
$0.2075 | $0.2185 | $0.2075 | $0.2185 | $0.2002 | 36,142 | 10-28-2020 |
$0.21 | $0.2012 | $0.21 | $0.23 | $0.2011 | 99,010 | 10-27-2020 |
$0.204 | $0.24 | $0.204 | $0.24 | $0.2001 | 113,077 | 10-26-2020 |
$0.225 | $0.220499 | $0.225 | $0.265 | $0.2197 | 202,214 | 10-23-2020 |
$0.2105 | $0.195 | $0.2105 | $0.24 | $0.195 | 149,753 | 10-22-2020 |
$0.21 | $0.2407 | $0.21 | $0.245 | $0.193 | 227,407 | 10-21-2020 |
$0.25 | $0.2295 | $0.25 | $0.264 | $0.22 | 173,178 | 10-20-2020 |
$0.2348 | $0.23 | $0.2348 | $0.2395 | $0.221 | 143,963 | 10-19-2020 |
$0.2077 | $0.2 | $0.2077 | $0.23 | $0.2 | 148,381 | 10-16-2020 |
$0.2 | $0.210049 | $0.2 | $0.227 | $0.1911 | 176,137 | 10-15-2020 |
$0.195 | $0.207 | $0.195 | $0.249 | $0.195 | 325,411 | 10-14-2020 |
$0.22 | $0.2222 | $0.22 | $0.23 | $0.21 | 119,285 | 10-13-2020 |
$0.2301 | $0.2505 | $0.2301 | $0.2505 | $0.22 | 230,054 | 10-12-2020 |
News, Short Squeeze, Breakout and More Instantly...
KBL Merger Corp. IV Warrant Company Name:
KBLMW Stock Symbol:
NASDAQ Market:
NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warra...
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp., a clinical-stage biotechnology company that has entered into a definitive merger agreement with KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant...
NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsWire — 180 Life Sciences Corp. today announces its placement in an editorial published by Network NewsWire ("NNW"), one of 50+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial new...